...
search icon
gnta-img

Genenta Science SpA ADR Share Price

GNTA
NAQ
$0.882
-$0.01
(-1.12%)
1D
Industry: Biotechnology Sector: Health Care

Genenta Science SpA ADR Analyst Forecast

Genenta Science SpA ADR Share Price Chart

Genenta Science SpA ADR Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$20.93M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
40.63K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.57
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.7 L
$6.2 H
$0.882

About Genenta Science SpA ADR, Common Stock

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. The company was incorporated in 2014 and is headquartered in Milan, Italy. more

Industry: BiotechnologySector: Health Care

Genenta Science SpA ADR Stock Returns

Time FrameGNTASectorS&P500
1-Week Return1.49%0.91%-0.82%
1-Month Return-33.84%1.46%1.28%
3-Month Return-55.12%3.33%3.98%
6-Month Return-75.05%16.03%6.73%
1-Year Return-78.06%9.1%12.24%
3-Year Return-86.87%21.02%72.07%
5-Year Return-91.88%36.15%75.69%

Genenta Science SpA ADR Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue1.77K5.08K6.03K41.58K-[{"date":"2020-12-31","value":4.26,"profit":true},{"date":"2021-12-31","value":12.23,"profit":true},{"date":"2022-12-31","value":14.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(1.77K)(5.08K)(6.03K)(41.58K)-[{"date":"2020-12-31","value":-177000,"profit":false},{"date":"2021-12-31","value":-508400,"profit":false},{"date":"2022-12-31","value":-602900,"profit":false},{"date":"2023-12-31","value":-4158200,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses5.59M5.69M11.04M11.73M9.76M[{"date":"2020-12-31","value":47.65,"profit":true},{"date":"2021-12-31","value":48.47,"profit":true},{"date":"2022-12-31","value":94.13,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":83.22,"profit":true}]
Operating Income(5.59M)(5.69M)(11.04M)(11.73M)(9.76M)[{"date":"2020-12-31","value":-559022600,"profit":false},{"date":"2021-12-31","value":-568727300,"profit":false},{"date":"2022-12-31","value":-1104399200,"profit":false},{"date":"2023-12-31","value":-1173294200,"profit":false},{"date":"2024-12-31","value":-976431000,"profit":false}]
Total Non-Operating Income/Expense(9.54K)146.22K2.60M396.74K932.96K[{"date":"2020-12-31","value":-0.37,"profit":false},{"date":"2021-12-31","value":5.62,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":15.24,"profit":true},{"date":"2024-12-31","value":35.84,"profit":true}]
Pre-Tax Income(5.59M)(5.53M)(8.48M)(11.65M)(8.91M)[{"date":"2020-12-31","value":-559201400,"profit":false},{"date":"2021-12-31","value":-552933200,"profit":false},{"date":"2022-12-31","value":-847776300,"profit":false},{"date":"2023-12-31","value":-1164545500,"profit":false},{"date":"2024-12-31","value":-891249500,"profit":false}]
Income Taxes13.72K31.37K(4.85M)4.00-[{"date":"2020-12-31","value":43.73,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-15468.46,"profit":false},{"date":"2023-12-31","value":0.01,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(5.61M)(5.56M)(3.62M)(11.65M)-[{"date":"2020-12-31","value":-560573400,"profit":false},{"date":"2021-12-31","value":-556070500,"profit":false},{"date":"2022-12-31","value":-362484400,"profit":false},{"date":"2023-12-31","value":-1164545900,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(5.59M)(5.53M)(8.48M)(11.65M)(8.91M)[{"date":"2020-12-31","value":-559201400,"profit":false},{"date":"2021-12-31","value":-552933200,"profit":false},{"date":"2022-12-31","value":-847776300,"profit":false},{"date":"2023-12-31","value":-1164545500,"profit":false},{"date":"2024-12-31","value":-891249500,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(5.61M)(5.53M)(8.48M)(11.65M)(8.91M)[{"date":"2020-12-31","value":-560573400,"profit":false},{"date":"2021-12-31","value":-552933200,"profit":false},{"date":"2022-12-31","value":-847776300,"profit":false},{"date":"2023-12-31","value":-1164545500,"profit":false},{"date":"2024-12-31","value":-891249500,"profit":false}]
EPS (Diluted)(0.51)---(0.43)[{"date":"2020-12-31","value":-51.14,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-43.25,"profit":false}]

Genenta Science SpA ADR Ratios

Genenta Science SpA ADR Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

GNTA
Cash Ratio 11.10
Current Ratio 13.20

Genenta Science SpA ADR Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GNTA
ROA (LTM) -26.59%
ROE (LTM) -60.15%

Genenta Science SpA ADR Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GNTA
Debt Ratio Lower is generally better. Negative is bad. 0.44
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.56

Genenta Science SpA ADR Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GNTA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.43
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Genenta Science SpA ADR share price today?

Genenta Science SpA ADR (GNTA) share price today is $0.882

Can Indians buy Genenta Science SpA ADR shares?

Yes, Indians can buy shares of Genenta Science SpA ADR (GNTA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GNTA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Genenta Science SpA ADR be purchased?

Yes, you can purchase fractional shares of Genenta Science SpA ADR (GNTA) via the Vested app. You can start investing in Genenta Science SpA ADR (GNTA) with a minimum investment of $1.

How to invest in Genenta Science SpA ADR shares from India?

You can invest in shares of Genenta Science SpA ADR (GNTA) via Vested in three simple steps:

  • Click on Sign Up or Invest in GNTA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Genenta Science SpA ADR shares
What is Genenta Science SpA ADR 52-week high and low stock price?

The 52-week high price of Genenta Science SpA ADR (GNTA) is $6.2. The 52-week low price of Genenta Science SpA ADR (GNTA) is $0.7.

What is Genenta Science SpA ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Genenta Science SpA ADR (GNTA) is

What is Genenta Science SpA ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Genenta Science SpA ADR (GNTA) is 1.43

What is Genenta Science SpA ADR dividend yield?

The dividend yield of Genenta Science SpA ADR (GNTA) is 0.00%

What is the Market Cap of Genenta Science SpA ADR?

The market capitalization of Genenta Science SpA ADR (GNTA) is $20.93M

What is Genenta Science SpA ADR's stock symbol?

The stock symbol (or ticker) of Genenta Science SpA ADR is GNTA

How Can Investors Use Genenta Science SpA ADR Share Price Data for Long-Term Investment Decisions?

Consider the share price of Genenta Science SpA ADR as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Genenta Science SpA ADR has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Genenta Science SpA ADR shares for Indian investors?

When investing in Genenta Science SpA ADR shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Genenta Science SpA ADR stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Genenta Science SpA ADR share price with other stocks in the same sector?

Rather than merely checking the share price of Genenta Science SpA ADR and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Genenta Science SpA ADR stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top